Xiang, Yirong
Li, Shuai
Song, Maxiaowei
Wang, Hongzhi
Hu, Ke
Wang, Fengwei
Wang, Zhi
Niu, Zhiyong
Liu, Jin
Cai, Yong
Li, Yongheng
Zhu, Xianggao
Geng, Jianhao
Zhang, Yangzi
Teng, Huajing
Wang, Weihu
Funding for this research was provided by:
Peking University Medicine Sailing Program for Young Scholars’Scientific & Technological Innovation (BMU2023YFJHPY022)
Beijing Hospitals Authority’s Ascent Plan (DFL 20220902)
Beijing Municipal Science and Technology Commission (Z181100001718192)
Capital’s Funds for Health Improvement and Research (2020-2-1027, 2020-1-4021)
National Natural Science Foundation of China (82073333, 32071156)
Article History
Received: 2 August 2023
Accepted: 5 December 2023
First Online: 12 December 2023
Declarations
:
: This retrospective multicentre study was conducted at two tertiary academic cancer institutions in China and was approved by the ethics committees of Peking University Cancer Hospital and Institute, the leading site and conducted in accordance with the Declaration of Helsinki. Participants signed informed consent forms before the study began.
: Not applicable.
: The authors declare no competing interests.